Opal Wealth Advisors, LLC Immunity Bio, Inc. Transaction History
Opal Wealth Advisors, LLC
- $361 Million
- Q4 2025
A detailed history of Opal Wealth Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Opal Wealth Advisors, LLC holds 14,325 shares of IBRX stock, worth $29,796. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,325Holding current value
$29,796% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
304Shares Held
143MCall Options Held
2.59MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA32.8MShares$68.2 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$26.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$23.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$14.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $833M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...